Midas Multispeciality Hospital Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 03-12-2024
- Paid Up Capital ₹ 0.10 M
as on 03-12-2024
- Company Age 14 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 62.00 Cr
as on 03-12-2024
- Revenue 39.74%
(FY 2022)
- Profit 86.07%
(FY 2022)
- Ebitda 75.61%
(FY 2022)
- Net Worth 30.53%
(FY 2022)
- Total Assets 37.23%
(FY 2022)
About Midas Multispeciality Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹62.00 Cr.
Mugdha Mukewar, Shrikant Mukewar, and Saurabh Mukewar serve as directors at the Company.
- CIN/LLPIN
U74900MH2010PTC207211
- Company No.
207211
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Aug 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Midas Multispeciality Hospital?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mugdha Mukewar  | Director | 28-Aug-2010 | Current |
| Shrikant Mukewar | Director | 28-Aug-2010 | Current |
| Saurabh Mukewar | Director | 01-Jan-2020 | Current |
Financial Performance of Midas Multispeciality Hospital.
Midas Multispeciality Hospital Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 39.74% increase. The company also saw a substantial improvement in profitability, with a 86.07% increase in profit. The company's net worth Soared by an impressive increase of 30.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Midas Multispeciality Hospital?
In 2022, Midas Multispeciality Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pranavayu Cluster Vidarbha Hospital AssociationActive 3 years 6 monthsShrikant Mukewar is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 21 Aug 2023 | ₹17.00 Cr | Open |
Others Creation Date: 25 Feb 2022 | ₹42.00 Cr | Open |
Others Creation Date: 25 Feb 2022 | ₹3.00 Cr | Open |
How Many Employees Work at Midas Multispeciality Hospital?
Midas Multispeciality Hospital has a workforce of 178 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Midas Multispeciality Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Midas Multispeciality Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
